SUBLOCADE 100 MG / 0.5 ML
BUPRENORPHINE : 100 MG / 0.5 ML · DIN 02483084 · INDIVIOR UK LIMITED
Health Canada status: MARKETED
What is SUBLOCADE?
SUBLOCADE 100 MG / 0.5 ML contains BUPRENORPHINE : 100 MG / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02483084, held by INDIVIOR UK LIMITED, supplied as SOLUTION (EXTENDED RELEASE) for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 03-Feb-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SUBLOCADE used for?
Management of moderate to severe opioid use disorder in adult patients, as part of a complete treatment plan including counselling and psychosocial support.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02483084 |
|---|---|
| Brand name | SUBLOCADE |
| Generic / active ingredient | BUPRENORPHINE : 100 MG / 0.5 ML |
| Manufacturer | INDIVIOR UK LIMITED |
| Strength | 100 MG / 0.5 ML |
| Dosage form | SOLUTION (EXTENDED RELEASE) |
| Route of administration | SUBCUTANEOUS |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N07BC01 BUPRENORPHINE |
| AHFS class | 52:32.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 03-Feb-2020 |
How is it administered?
Subcutaneous injection only. Initial: 300 mg monthly for 2 months. Maintenance: 100 mg monthly. Can be initiated via Rapid Induction or after 7-day transmucosal buprenorphine stabilization.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Refrigerate at 2-8°C. Once outside the refrigerator, may be stored at room temperature (up to 25°C) for up to 28 days. Discard if left at room temperature >28 days.
How is it supplied?
Prefilled syringe with safety needle (100 mg / 0.5 mL or 300 mg / 1.5 mL). Available through a controlled distribution process.
Contraindications
Hypersensitivity; severe respiratory insufficiency; severe hepatic impairment; acute alcoholism; GI obstruction; severe CNS depression; MAO inhibitors; seizure disorders; Long QT Syndrome.
Warnings and precautions
Serious harm/death if administered IV. Risk of addiction, abuse, misuse. Life-threatening respiratory depression. QTc prolongation. Risk of profound sedation with CNS depressants.
What can be used instead?
Other Canadian products sharing ATC code N07BC01 BUPRENORPHINE. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SUBLOCADE | 300 MG / 1.5 ML | SOLUTION (EXTENDED RELEASE) | INDIVIOR UK LIMITED | MARKETED | DIN 02483092 |
| PROBUPHINE | 80 MG | IMPLANT | KNIGHT THERAPEUTICS INC. | CANCELLED POST MARKET | DIN 02474921 |
Who else supplies BUPRENORPHINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BUPRENORPHINE appears in 392 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.